{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:12:51Z","timestamp":1762459971348,"version":"build-2065373602"},"reference-count":86,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001343","name":"University of Pretoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jcyt.2021.02.116","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T07:34:11Z","timestamp":1617694451000},"page":"548-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Perspectives on establishing a public cord blood inventory in South Africa"],"prefix":"10.1016","volume":"23","author":[{"given":"Ignatius M.","family":"Viljoen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candice Laverne","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanita","family":"Mellet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5930","key":"10.1016\/j.jcyt.2021.02.116_bib0001","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1126\/science.1172257","article-title":"The genetic structure and history of Africans and African Americans","volume":"324","author":"Tishkoff","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0002","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1101\/sqb.2009.74.053","article-title":"Genetic structure in African populations: implications for human demographic history","volume":"74","author":"Lambert","year":"2009","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"4","key":"10.1016\/j.jcyt.2021.02.116_bib0003","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ajhg.2010.02.014","article-title":"Strong Maternal Khoisan Contribution to the South African Coloured Population: A Case of Gender-Biased Admixture","volume":"86","author":"Quintana-Murci","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"P0302","key":"10.1016\/j.jcyt.2021.02.116_bib0004","first-page":"1","article-title":"Mid-Year Population Estimates 2020","year":"2020","journal-title":"Pretoria"},{"issue":"12","key":"10.1016\/j.jcyt.2021.02.116_bib0005","doi-asserted-by":"crossref","first-page":"e82224","DOI":"10.1371\/journal.pone.0082224","article-title":"A panel of ancestry informative markers for the complex five-way admixed South African Coloured population","volume":"8","author":"Daya","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0006","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.genom.9.081307.164258","article-title":"African Genetic Diversity: Implications for Human Demographic History, Modern Human Origins, and Complex Disease Mapping","volume":"9","author":"Cambell","year":"2008","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"1","key":"10.1016\/j.jcyt.2021.02.116_bib0007","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/s41467-017-00663-9","article-title":"Whole-genome sequencing for an enhanced understanding of genetic variation among South Africans","volume":"8","author":"Choudhury","year":"2017","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.jcyt.2021.02.116_bib0008","doi-asserted-by":"crossref","first-page":"e78410","DOI":"10.1371\/journal.pone.0078410","article-title":"HLA Typing from 1000 Genomes Whole Genome and Whole Exome Illumina Data. Seo J-S, ed","volume":"8","author":"Major","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jcyt.2021.02.116_bib0009","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5500\/wjt.v6.i3.532","article-title":"Genetic barriers in transplantation medicine","volume":"6","author":"Edinur","year":"2016","journal-title":"World J Transplant"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0010","first-page":"42","volume":"2","author":"du Toit","year":"1988"},{"issue":"3","key":"10.1016\/j.jcyt.2021.02.116_bib0011","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1399-0039.1988.tb02072.x","article-title":"HLA-A, B, C, DR and DQ polymorphisms in three South African population groups: South African Negroes, Cape Coloureds and South African Caucasoids","volume":"31","author":"du Toit","year":"1988","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0013","doi-asserted-by":"crossref","unstructured":"Tshabalala M, Mellet J, Vather K, et\u00a0al. Mixed Resolution HLA~A, ~B, ~C, ~DRB1, ~DQA1, ~DQB1 and ~DPB1 Diversity in South African Populations. Unpublished manuscript. Submitted 2021","DOI":"10.3389\/fgene.2022.711944"},{"issue":"1","key":"10.1016\/j.jcyt.2021.02.116_bib0014","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.humimm.2011.10.013","article-title":"Human leukocyte antigen class I (A, B, C) and II (DRB1) diversity in the black and Caucasian South African population","volume":"73","author":"Paximadis","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0015","first-page":"D783","article-title":"Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools","volume":"48(D1)","author":"Gonzalez-Galarza","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.jcyt.2021.02.116_bib0016","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.humimm.2019.12.003","article-title":"Human leukocyte antigen class I (A, B, C) and class II (DPB1, DQB1, DRB1) allele and haplotype variation in Black South African individuals","volume":"81","author":"Loubser","year":"2020","journal-title":"Hum Immunol"},{"issue":"3","key":"10.1016\/j.jcyt.2021.02.116_bib0017","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.humimm.2018.01.004","article-title":"Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 159 individuals from the Worcester region of the Western Cape province of South Africa","volume":"79","author":"Grifoni","year":"2018","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2021.02.116_bib0018","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.humimm.2019.12.003","article-title":"Human leukocyte antigen class I (A, B, C) and class II (DPB1, DQB1, DRB1) allele and haplotype variation in Black South African individuals","volume":"81","author":"Loubser","year":"2020","journal-title":"Hum Immunol"},{"issue":"8","key":"10.1016\/j.jcyt.2021.02.116_bib0019","first-page":"293","article-title":"The South African Bone Marrow Registry\u2014role in providing unrelated donors for allogeneic stem cell transplantation","volume":"30","author":"du Toit","year":"2012","journal-title":"Contin Med Educ J"},{"issue":"4","key":"10.1016\/j.jcyt.2021.02.116_bib0021","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jcyt.2021.02.116_bib0022","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/sctm.19-0288","article-title":"Umbilical cord blood: The promise and the uncertainty","volume":"9","author":"Kindwall-Keller","year":"2020","journal-title":"Stem Cells Transl Med"},{"issue":"9","key":"10.1016\/j.jcyt.2021.02.116_bib0023","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/ijc.30249","article-title":"Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia","volume":"139","author":"Mo","year":"2016","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.jcyt.2021.02.116_bib0024","first-page":"1","article-title":"Unrelated cord blood transplantation versus haploidentical transplantation in adult and pediatric patients with hematological malignancies\u2014a meta-analysis and systematic review","volume":"10","author":"Li","year":"2020","journal-title":"Am J Blood Res"},{"issue":"1","key":"10.1016\/j.jcyt.2021.02.116_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-018-0655-8","article-title":"Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine","volume":"11","author":"Giannotti","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0026","first-page":"1","article-title":"Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant","volume":"000","author":"Solomon","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2021.02.116_bib0027","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bbmt.2019.10.014","article-title":"Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies","volume":"26","author":"Sanz","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2021.02.116_bib0028","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood.2020007535","article-title":"Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial","volume":"137","author":"Fuchs","year":"2021","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jcyt.2021.02.116_bib0029","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/pbc.26131","article-title":"Haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide in children and adolescents with hematological malignancies","volume":"63","author":"Gonz\u00e1lez-Llano","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.jcyt.2021.02.116_bib0030","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after ab T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.jcyt.2021.02.116_bib0031","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood-2018-07-861575","article-title":"Unrelated donor vs HLA-haploidentical \u03b1\/\u03b2 T-cell\u2013 and B-cell\u2013depleted HSCT in children with acute leukemia","volume":"132","author":"Bertaina","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcyt.2021.02.116_bib0032","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bbmt.2017.03.001","article-title":"Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection","volume":"23","author":"Kosuri","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2021.02.116_bib0033","first-page":"1","article-title":"Fragmenting the Family? The Complexity of Household Migration Strategies in Post-Apartheid South Africa","volume":"10","author":"Hall","year":"2019","journal-title":"IZA J Dev Migr"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0035","unstructured":"UNAIDS. Country factsheets South Africa | 2019 [Internet]. 2019. p. 1\u201310. Available from https:\/\/www.unaids.org\/en\/regionscountries\/countries\/southafrica. Accessed 25 March 2021."},{"issue":"6","key":"10.1016\/j.jcyt.2021.02.116_bib0036","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s13312-018-1340-2","article-title":"Umbilical Cord Blood Banking: Consensus Statement of the Indian Academy of Pediatrics","volume":"55","author":"Sachdeva","year":"2018","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/572821","article-title":"Insights and Hopes in Umbilical Cord Blood Stem Cell Transplantations","volume":"2012","author":"Shahrokhi","year":"2012","journal-title":"J Biomed Biotechnol"},{"issue":"4","key":"10.1016\/j.jcyt.2021.02.116_bib0038","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40592-015-0048-5","article-title":"From waste to (fool's) gold\u00a0: promissory and profit values of cord blood","volume":"33","author":"Haw","year":"2015","journal-title":"Monash Bioeth Rev"},{"issue":"11","key":"10.1016\/j.jcyt.2021.02.116_bib0039","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3324\/haematol.2011.047050","article-title":"Family-directed umbilical cord blood banking","volume":"96","author":"Gluckman","year":"2011","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.jcyt.2021.02.116_bib0040","first-page":"116","article-title":"Cord Blood Banking for Potential Future Transplantation: Subject Review","volume":"104","author":"Shearer","year":"2017","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.jcyt.2021.02.116_bib0041","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/sctm.17-0244","article-title":"Factors Influencing the Umbilical Cord Blood Stem Cell Industry: An Evolving Treatment Landscape","volume":"7","author":"Dessels","year":"2018","journal-title":"Stem Cells Transl Med"},{"issue":"12","key":"10.1016\/j.jcyt.2021.02.116_bib0042","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"},{"year":"2017","series-title":"Challenges to the Sustainability of the U.S. Public Cord Blood System","author":"Kapinos","key":"10.1016\/j.jcyt.2021.02.116_bib0043"},{"issue":"12","key":"10.1016\/j.jcyt.2021.02.116_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0143440","article-title":"Banking or Bankrupting\u00a0: Strategies for Sustaining the Economic Future of Public Cord Blood Banks","volume":"10","author":"Magalon","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jcyt.2021.02.116_bib0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000345690","article-title":"Impact of Selection of Cord Blood Units from the United States and Swiss Registries on the Cost of Banking Operations","volume":"40","author":"Bart","year":"2013","journal-title":"Transfus Med Hemotherapy"},{"issue":"1","key":"10.1016\/j.jcyt.2021.02.116_bib0046","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/CEOR.S11210","article-title":"Cost effectiveness of cord blood versus bone marrow and peripheral blood stem cells","volume":"2","author":"Bart","year":"2010","journal-title":"Clin Outcomes Res"},{"issue":"9","key":"10.1016\/j.jcyt.2021.02.116_bib0047","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jval.2018.03.003","article-title":"On the Value of the Umbilical Cord Blood Supply","volume":"21","author":"Strong","year":"2018","journal-title":"Value Heal"},{"issue":"3","key":"10.1016\/j.jcyt.2021.02.116_bib0048","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood-2004-07-2717","article-title":"Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy","volume":"105","author":"Barker","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jcyt.2021.02.116_bib0049","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbmt.2015.09.025","article-title":"Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation","volume":"22","author":"Brunstein","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2021.02.116_bib0050","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/sctm.17-0075","article-title":"A History of Cord Blood Banking and Transplantation","volume":"6","author":"Kurtzberg","year":"2017","journal-title":"Stem Cells Transl Med"},{"issue":"18","key":"10.1016\/j.jcyt.2021.02.116_bib0051","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1405584","article-title":"One-Unit versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers","volume":"371","author":"Wagner","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.jcyt.2021.02.116_bib0052","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1182\/blood-2016-01-694349","article-title":"Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome","volume":"127","author":"Michel","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jcyt.2021.02.116_bib0053","first-page":"141","article-title":"Notch Mediated Expansion of human CB progenitor cells capable of rapid myeloid reconstitition","volume":"266","author":"Delaney","year":"2010","journal-title":"J Intern Med"},{"issue":"8","key":"10.1016\/j.jcyt.2021.02.116_bib0054","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.bbmt.2017.05.002","article-title":"Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery","volume":"23","author":"Mehta","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jcyt.2021.02.116_bib0055","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1172\/JCI74556","article-title":"Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment","volume":"124","author":"Horwitz","year":"2014","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jcyt.2021.02.116_bib0056","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1200\/JCO.18.00053","article-title":"Phase I\/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide","volume":"37","author":"Horwitz","year":"2019","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.jcyt.2021.02.116_bib0057","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.bbmt.2018.02.012","article-title":"Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor\u2013Enriched Cord Blood, to Double Cord Blood Unit Transplantation","volume":"24","author":"Stiff","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2021.02.116_bib0058","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.stem.2015.10.004","article-title":"Phase I\/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft","volume":"18","author":"Wagner","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"25","key":"10.1016\/j.jcyt.2021.02.116_bib0059","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2016-11-750729","article-title":"EPCR expression marks UM171-expanded CD34+ cord blood stem cells","volume":"129","author":"Fares","year":"2017","journal-title":"Blood"},{"issue":"6203","key":"10.1016\/j.jcyt.2021.02.116_bib0060","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.1256337","article-title":"Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal","volume":"345","author":"Fares","year":"2014","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jcyt.2021.02.116_bib0061","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41409-018-0275-5","article-title":"Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean\/African region: comparison with global HSCT indications and trends","volume":"54","author":"Baldomero","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0062","unstructured":"Health Resources and Services Administration. Donation and Transplantation Statistics. https:\/\/bloodstemcell.hrsa.gov\/about\/faqs. Accessed September 23, 2020."},{"issue":"6","key":"10.1016\/j.jcyt.2021.02.116_bib0063","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/bmt.2016.20","article-title":"Hematopoietic stem cell transplantation in Europe 2014: More than 40 000 transplants annually","volume":"51","author":"Passweg","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jcyt.2021.02.116_bib0064","first-page":"47","article-title":"Haematopoietic stem cell transplantation in South Africa: current limitations and future perspectives","volume":"109","author":"Grobbelaar","year":"2019","journal-title":"SAMJ"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0065","first-page":"106","article-title":"Demography of South Africa's children","volume":"2016","author":"Hall","year":"2015","journal-title":"South African Child Gauge"},{"issue":"9693","key":"10.1016\/j.jcyt.2021.02.116_bib0066","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0140-6736(09)61087-4","article-title":"The burden of non-communicable diseases in South Africa","volume":"374","author":"Mayosi","year":"2009","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jcyt.2021.02.116_bib0067","doi-asserted-by":"crossref","first-page":"e642","DOI":"10.1016\/S2214-109X(16)30113-9","article-title":"Mortality trends and differentials in South Africa from 1997 to 2012: Second National Burden of Disease Study","volume":"4","author":"Pillay-van Wyk","year":"2016","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0068","series-title":"Cancer incidence in selected municipalities of the Eastern Cape Province, 2008\u20132012. Eastern Cape Province Cancer Registry Technical Report","first-page":"1","author":"Somdyala","year":"2015"},{"issue":"627","key":"10.1016\/j.jcyt.2021.02.116_bib0069","first-page":"1","article-title":"White Paper: National Health Insurance Policy\u2014Towards Universal Health Coverage","volume":"40955","year":"2017","journal-title":"Government Notice"},{"issue":"6","key":"10.1016\/j.jcyt.2021.02.116_bib0076","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s12015-013-9463-2","article-title":"Establishing a public umbilical cord blood stem cell bank for South Africa: an enquiry into public acceptability","volume":"9","author":"Meissner-Roloff","year":"2013","journal-title":"Stem Cell Rev Reports"},{"issue":"4","key":"10.1016\/j.jcyt.2021.02.116_bib0077","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nbt.2866","article-title":"The third way of umbilical cord blood banking","volume":"32","author":"Chang","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0078","unstructured":"CELVI. CELVI_Join the Movement! https:\/\/mdaltd.org.au\/. Published 2019. Accessed August 19, 2020."},{"key":"10.1016\/j.jcyt.2021.02.116_bib0079","first-page":"313","article-title":"A cost analysis of public cord blood banks belonging to the Italian Cord Blood network","volume":"16","author":"Pupella","year":"2018","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0080","first-page":"1","article-title":"The 2017 National Antenatal Sentinel HIV Survey Key Findings","volume":"27","author":"Woldesenbet","year":"2019","journal-title":"Pretoria"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0081","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7196\/SAMJ.2017.v108i3b.12817","article-title":"Closing the gaps to eliminate mother-to-child transmission of HIV (MTCT) in South Africa: understanding MTCT case rates, factors that hinder the monitoring and attainment of targets, and potential game changers","volume":"108","author":"Goga","year":"2018","journal-title":"South African Med J"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0082","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1017\/gheg.2018.6","article-title":"Strategies for screening cord blood for a public cord blood bank in high HIV prevalence regions","volume":"3","author":"Meissner-Roloff","year":"2018","journal-title":"Glob Heal Epidemiol Genomics"},{"issue":"7","key":"10.1016\/j.jcyt.2021.02.116_bib0083","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1111\/trf.15313","article-title":"Reducing ethnic disparity in access to high-quality HLA-matched cord blood units for transplantation: analysis of the Canadian Blood Services\u2019 Cord Blood Bank inventory","volume":"59","author":"Allan","year":"2019","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.jcyt.2021.02.116_bib0084","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/heapol\/czz152","article-title":"Estimating a cost-effectiveness threshold for health care decision-making in South Africa","volume":"35","author":"Edoka","year":"2020","journal-title":"Health Policy Plan"},{"issue":"5","key":"10.1016\/j.jcyt.2021.02.116_bib0085","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1309\/AJCPFB6EXO7BJVLR","article-title":"Evaluation of Volume and Total Nucleated Cell Count as Cord Blood Selection Parameters","volume":"136","author":"Jaime-P\u00e9rez","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jcyt.2021.02.116_bib0087","doi-asserted-by":"crossref","unstructured":"Gupta AO, Wagner JE. Umbilical Cord Blood Transplants: Current Status and Evolving Therapies. Front Pediatr. 2020;8:1-11.","DOI":"10.3389\/fped.2020.570282"},{"issue":"10","key":"10.1016\/j.jcyt.2021.02.116_bib0088","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/sctm.19-0288","article-title":"Umbilical cord blood: The promise and the uncertainty","volume":"9","author":"Kindwall-Keller","year":"2020","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"10.1016\/j.jcyt.2021.02.116_bib0089","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/bmt.2014.329","article-title":"Constituting a public umbilical cord blood bank in South Africa","volume":"50","author":"Mellet","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"1002","key":"10.1016\/j.jcyt.2021.02.116_bib90","first-page":"1","article-title":"Medicines and Related Substances Act No. 101 of 1965 as ammended","volume":"1171","year":"1965","journal-title":"Government Gazette"},{"issue":"GN 859","key":"10.1016\/j.jcyt.2021.02.116_bib91","first-page":"1","article-title":"General Regulations to the Medicines and Related Substances Act 101 of 1965 (as amended to August 2017)","year":"2017","journal-title":"South African Government Gazette"},{"issue":"GN R183","key":"10.1016\/j.jcyt.2021.02.116_bib92","first-page":"1","article-title":"Regulations Relating to Stem Cell Banks","volume":"35099","year":"2012","journal-title":"South African Government Gazette"},{"first-page":"1","year":"2012","series-title":"Standard Treatment Guidelines and Essential Medicines List for South Africa: Hospital Level","key":"10.1016\/j.jcyt.2021.02.116_bib94"},{"first-page":"1","year":"2020","series-title":"National Cancer Strategic Framework for South Africa 2017\u20142022","key":"10.1016\/j.jcyt.2021.02.116_bib95"},{"issue":"GN 869","key":"10.1016\/j.jcyt.2021.02.116_bib96","first-page":"1","article-title":"National Health Act No. 61 of 2003","volume":"26595","year":"2003","journal-title":"South African Government Gazette"},{"key":"10.1016\/j.jcyt.2021.02.116_bib98","series-title":"South African ChildGauge 2019 - Child and adolescent health - Leave no one behind","first-page":"216","article-title":"Demography of South Africa\u2019s children","year":"2019"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324921001729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324921001729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:43:51Z","timestamp":1761443031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324921001729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1465324921001729"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2021.02.116","relation":{},"ISSN":["1465-3249"],"issn-type":[{"type":"print","value":"1465-3249"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perspectives on establishing a public cord blood inventory in South Africa","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2021.02.116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of International Society for Cell & Gene Therapy.","name":"copyright","label":"Copyright"}]}}